$4.130
+0.051 (+1.23%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de AQST por análisis de gráficos similares
Alphio's AQST stock price prediction model matches the current Aquestive Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.18 (+1.26%). The 1-week path is $4.24 (+2.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Aquestive Therapeutics, Inc.?
Currently, Aquestive Therapeutics Inc (AQST) is not a good buy. The stock is trading at $3.78, which is significantly below the analyst price target of $8, indicating potential upside. However, the stock has a very low RSI of 12.312, suggesting it is oversold, but this is accompanied by a concerning trend with a 5-day change of -20.92% and a year-to-date change of -41.40%. The recent insider selling has increased by 140.84%, which raises concerns about insider confidence in the company's future. The main risk is the negative net income, which was -22.9 million in Q2 2026, indicating ongoing financial struggles.
AQST cerró en $4.13 el Thursday, tras subir +1.23%
Aquestive Therapeutics, Inc. (AQST) last closed at $4.13, gaining +1.23%. These facts feed the 1-day and 1-week AQST price prediction above.
Consenso de analistas
Aquestive Therapeutics, Inc. (AQST): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Aquestive Therapeutics, Inc. (AQST) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de AQST, ordenadas por similitud.
Análisis de estacionalidad de AQST
Historically the probability of a positive October return for AQST is 73.02%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de AQST
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $1.65 | $2.12 | $2.20 | -48.79% |
| Nov 2026 | $1.91 | $2.12 | $2.51 | -48.79% |
| Dec 2026 | $2.43 | $2.61 | $2.66 | -36.92% |
En 2026, se proyecta que Aquestive Therapeutics, Inc. (AQST) oscile entre $1.65 y $2.66.
Previsión mensual de Aquestive Therapeutics, Inc. para 2026
En Oct de 2026, se proyecta que Aquestive Therapeutics, Inc. promedie $2.12, con un mínimo de $1.65 y un máximo de $2.20.
En Nov de 2026, se proyecta que Aquestive Therapeutics, Inc. promedie $2.12, con un mínimo de $1.91 y un máximo de $2.51.
En Dec de 2026, se proyecta que Aquestive Therapeutics, Inc. promedie $2.61, con un mínimo de $2.43 y un máximo de $2.66.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.